http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2075983-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1de90f354dd27775434f154d24ce6878 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-66 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-66 |
| filingDate | 1981-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1981-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-2075983-A |
| titleOfInvention | Pyridoxine derivatives, process for preparing them and use in therapeutics |
| abstract | Disclosed are pyridoxine derivatives represented by the general formula: <IMAGE> in which: R represents a radical <IMAGE> in which n represents 0 or 1, X and X1, which are different, represent hydrogen or methyl, Y represents hydrogen or methyl and R2 represents a phenyl group non-substituted or bearing one or two substituents selected from the group consisting of fluorine, chlorine and bromine and of the radicals methyl, ethyl, n-propyl, isopropyl and methoxy, and R1 represents hydrogen or a radical of formula <IMAGE> in which R3 represents a straight-chain alkyl radical having from 1 to 4 carbon atoms and pharmaceutically acceptable acid addition salts thereof. In addition to possessing ???- antiadrenergic properties, some of these compounds also exhibit ???- antiadrenergic, antihypertensive and central depressant effects. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1872797-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1872797-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004084910-A1 |
| priorityDate | 1980-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.